Healthcare firms have done comparatively well in an otherwise subdued U.S. IPO market in 2024, which analysts touted as a comeback year for public offerings. The Richmond, California-based company ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, 2024, as the Federal Reserve announced its first interest-rate cut since ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.

The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...

NEW YORK (Reuters) - U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo ...

ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...